Ongoing Ebola transmission in the Democratic Republic of the Congo, where the Bundibugyo strain has driven thousands of confirmed cases since the May 2026 outbreak declaration, anchors trader focus on core African markets while imported cases in Uganda (now resolved) and isolated reports elsewhere highlight cross-border risks. International health responses, including expanded funding and containment measures, have contained spread so far, but sustained community transmission in DRC provinces keeps attention on potential new country entries before year-end. Traders watch for updates on case trajectories, border dynamics, and any fresh confirmations that could shift implied probabilities for additional nations amid the high-uncertainty public health landscape.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoWhich countries will have an Ebola case in 2026?
Which countries will have an Ebola case in 2026?
$32,095 Vol.
31 dic 2026
South Sudan
63%
Rwanda
30%
Burundi
27%
United States
22%
Canada
28%
Kenya
49%
India
22%
Republic of the Congo
21%
Nigeria
22%
Ethiopia
48%
Somalia
34%
China
22%
$32,095 Vol.
South Sudan
$1,769 Vol.
63%
Rwanda
$2,128 Vol.
30%
Burundi
$200 Vol.
27%
United States
$9,586 Vol.
22%
Canada
$1,086 Vol.
28%
Kenya
$193 Vol.
49%
India
$732 Vol.
22%
Republic of the Congo
$11,674 Vol.
21%
Nigeria
$25 Vol.
22%
Ethiopia
$65 Vol.
48%
Somalia
$71 Vol.
34%
China
$2,610 Vol.
22%
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.Ongoing Ebola transmission in the Democratic Republic of the Congo, where the Bundibugyo strain has driven thousands of confirmed cases since the May 2026 outbreak declaration, anchors trader focus on core African markets while imported cases in Uganda (now resolved) and isolated reports elsewhere highlight cross-border risks. International health responses, including expanded funding and containment measures, have contained spread so far, but sustained community transmission in DRC provinces keeps attention on potential new country entries before year-end. Traders watch for updates on case trajectories, border dynamics, and any fresh confirmations that could shift implied probabilities for additional nations amid the high-uncertainty public health landscape.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Mercado abierto: May 22, 2026, 12:35 PM ET
Volumen
$32,095Fecha de finalización
31 dic 2026Mercado abierto
May 22, 2026, 12:35 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.Ongoing Ebola transmission in the Democratic Republic of the Congo, where the Bundibugyo strain has driven thousands of confirmed cases since the May 2026 outbreak declaration, anchors trader focus on core African markets while imported cases in Uganda (now resolved) and isolated reports elsewhere highlight cross-border risks. International health responses, including expanded funding and containment measures, have contained spread so far, but sustained community transmission in DRC provinces keeps attention on potential new country entries before year-end. Traders watch for updates on case trajectories, border dynamics, and any fresh confirmations that could shift implied probabilities for additional nations amid the high-uncertainty public health landscape.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Volumen
$32,095Fecha de finalización
31 dic 2026Mercado abierto
May 22, 2026, 12:35 PM ETResolver
0x65070BE91...Ongoing Ebola transmission in the Democratic Republic of the Congo, where the Bundibugyo strain has driven thousands of confirmed cases since the May 2026 outbreak declaration, anchors trader focus on core African markets while imported cases in Uganda (now resolved) and isolated reports elsewhere highlight cross-border risks. International health responses, including expanded funding and containment measures, have contained spread so far, but sustained community transmission in DRC provinces keeps attention on potential new country entries before year-end. Traders watch for updates on case trajectories, border dynamics, and any fresh confirmations that could shift implied probabilities for additional nations amid the high-uncertainty public health landscape.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes